FDA challenges stem cell therapy companies

FDA wings
The Food and Drug Administration is stepping up its oversight of companies selling unproven and unlicensed stem-cell therapies and emerging industry with a spotty ethical and medical track record.
 
View the original article here: FDA challenges stem cell therapy companies
{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
screenshot at  pm

Are pesticide residues on food something to worry about?

In 1962, Rachel Carson’s Silent Spring drew attention to pesticides and their possible dangers to humans, birds, mammals and the ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.